France Cataract Surgery Devices Market Overview,2030

France’s cataract surgery devices market has evolved from a largely hospital-centred, manually driven practice in the late 20th century to a dynamic, technology-led segment today, driven by an aging population, rising patient expectations for faster recovery and better refractive outcomes, and steady reimbursement policies that make sight-restoring procedures widely accessible. The historical arc in France mirrors wider European trends as early adoption of intraocular lenses (IOLs) and phacoemulsification gave way in the 2000s to increasing uptake of premium IOLs such as multifocal, extended-depth-of-focus and toric lenses. Demand remains underpinned by demographic realities as France’s growing geriatric cohort has raised cataract prevalence and procedural volumes year on year, along with heightened patient awareness and willingness to pay for premium visual outcomes, which together buoy the market for both implants and related disposables and lasers. Commercially, manufacturers and distributors promote products through targeted professional education such as symposia, surgical wet labs, and peer-to-peer surgeon programs, along with clinical evidence generation and key opinion leader partnerships. Direct-to-patient messaging is carefully calibrated because France applies strict rules to advertising of health products; promotional activity aimed at clinicians must comply with the French Public Health Code and ANSM guidance, and public advertising is tightly regulated to avoid misleading claims. On the regulatory front, market access in France is governed first by conformity with EU regulations and CE marking under the Medical Device Regulation (MDR), and then by French national pathways.

According to the research report ""France Cataract Surgery Devices Market Overview, 2030,"" published by Bonafide Research, the France Cataract Surgery Devices market is anticipated to grow at 5.03% CAGR from 2025 to 2030. The ophthalmic and cataract segment is one of the fastest-growing categories within medical devices in France, with multiple market reports projecting steady CAGR driven by aging and innovation. Premium IOLs, femtosecond lasers, and advanced imaging are the fastest-growing subsegments, and regulatory scrutiny has increased since MDR implementation, raising conformity and clinical data expectations for manufacturers. For marketing and commercial strategy, this landscape means companies must invest in high-quality clinical data, strong surgeon training programs, compliant and transparent communications especially for public-facing materials, and a clear value proposition to health payers and hospitals. A combined approach that aligns innovation, evidence, and regulatory compliance is now essential to succeed in France’s cataract surgery devices market. ANSM and health technology assessment bodies such as HAS play roles in oversight, reimbursement decisions, and specific national requirements for advertising and safety reporting. This means manufacturers must compile robust technical dossiers, clinical evidence, and quality management system documentation to place devices on the French market. French ophthalmologists have shown early interest in adopting advanced surgical systems, such as laser-assisted phacoemulsification and intraoperative aberrometry, which enhance surgical precision and visual outcomes. The introduction of multifocal, toric, and extended depth-of-focus IOLs has transformed post-operative experiences by reducing dependence on glasses, making them highly popular among patients seeking lifestyle improvements. These innovations are supported by ongoing research collaborations between French universities, ophthalmic research institutes, and global device manufacturers.

Intraocular lenses (IOLs) hold the largest share of the French market, as cataract surgery is the most frequently performed ophthalmic procedure in the nation, largely covered by France’s public health insurance (Sécurité Sociale). Standard monofocal IOLs remain predominant within public hospitals due to reimbursement limitations, yet there is a noticeable rise in demand for premium IOLs, such as toric, multifocal, and extended depth-of-focus variants, especially in private and semi-private facilities where patients are willing to cover the additional cost for improved vision quality. Phacoemulsification systems represent the technological backbone of cataract surgery in France, with hospitals and clinics widely equipped with advanced machines from manufacturers like Alcon, Carl Zeiss Meditec, and Bausch + Lomb, ensuring precision, efficiency, and reduced surgical time. The use of ophthalmic viscoelastic devices (OVDs) continues to grow as surgeons prioritize corneal protection and intraocular pressure stability, supporting the country’s shift toward minimally invasive cataract surgery. Adoption of femtosecond laser systems is also increasing, mainly in high-end private clinics and ophthalmic centers, where patients seek bladeless, computer-guided surgeries offering higher safety and precision. The other devices segment including surgical blades, disposable cannulas, forceps, and low-cost consumables plays a vital supporting role, particularly within France’s regional hospitals and public facilities that emphasize cost control while maintaining high surgical standards.

Hospitals, particularly public and university hospitals, perform the majority of cataract surgeries under the national health system, providing accessible treatment to citizens across all regions. These institutions are equipped with advanced phacoemulsification systems and OVDs, ensuring standardized procedures and consistent patient outcomes. Meanwhile, ambulatory surgery centers (ASCs) are experiencing significant growth as part of France’s healthcare modernization efforts, which aim to reduce inpatient hospital stays and enhance efficiency through outpatient care models. ASCs are increasingly adopting compact, high-performance surgical systems and play a major role in reducing wait times for cataract operations. Ophthalmology clinics, including specialized private centers, are also expanding rapidly, driven by rising demand for elective cataract surgeries and premium IOL implantation, particularly among elderly populations seeking advanced vision correction solutions. These clinics often integrate advanced imaging, diagnostics, and femtosecond laser systems to offer personalized treatments. Academic and research institutes, such as the Quinze-Vingts National Ophthalmology Hospital and the Vision Institute in Paris, contribute significantly to technological innovation, clinical trials, and surgeon training, frequently collaborating with device manufacturers to pioneer new techniques and instruments.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Cataract Surgery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Intra-ocular Lenses (IOL)
• Phacoemulsification Systems
• Ophthalmic Viscoelastic Devices
• Femtosecond Laser Systems
• Others (Knives and Low-Cost Consumables)

By End User
• Hospitals
• Ambulatory Surgery Centers
• Ophthalmology Clinics
• Academic and Research Institutes Show more